← FDA DRUG APPROVALS

FDA ANDA · ANDA209107

CETIRIZINE HYDROCHLORIDE (ALLERGY)

cetirizine hydrochloride

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA209107
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-20
LATEST ACTION
2018-07-20
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter

Products

CETIRIZINE HYDROCHLORIDE ALLERGYOver-the-counter
CETIRIZINE HYDROCHLORIDE 10MG · CAPSULE · ORAL
CETIRIZINE HYDROCHLORIDE HIVES RELIEFOver-the-counter
CETIRIZINE HYDROCHLORIDE 10MG · CAPSULE · ORAL

Approval history

2018-07-20UNKNOWN · Original · standard — Letter ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →